The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India

INTRODUCTION: Dolutegravir (DTG)‐based antiretroviral therapy (ART) is recommended for first‐line HIV treatment in the US and Europe. Efavirenz (EFV)‐based regimens remain the standard of care (SOC) in India. We examined the clinical and economic impact of DTG‐based first‐line ART in the setting of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Amy, Kumarasamy, Nagalingeswaran, Huang, Mingshu, Paltiel, A David, Mayer, Kenneth H, Rewari, Bharat B, Walensky, Rochelle P, Freedberg, Kenneth A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878415/
https://www.ncbi.nlm.nih.gov/pubmed/29603882
http://dx.doi.org/10.1002/jia2.25085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878415/
https://www.ncbi.nlm.nih.gov/pubmed/29603882
http://dx.doi.org/10.1002/jia2.25085

Ejemplares similares